Science

National Research Development Corporation inks 5 tech licensing pacts

M Somasekhar Hyderabad | Updated on January 15, 2018 Published on November 01, 2016

The other licenced technology includes a process for isolation of a major harmful oxidant i.e., parabenzosemiquinone from cigarette smoke.

National Research Development Corporation (NRDC) has signed five technology licensing agreements on a single day.

The technologies licenced include three Ayurvedic technologies to Ayur Force organics, New Delhi. The technologies have been developed by CCRAS — Ayurvedic anti-diabetic drug and one for treatment of Rheumatoid Arthritis; CSIR-NEIST a arthritis herbal formulation. Swadesi Ayurved, Hardwar acquired the Ayush-82 technology.

The other licenced technology includes a process for isolation of a major harmful oxidant i.e., parabenzosemiquinone from cigarette smoke.

Licensing agreement

The know-how was developed by Kolkata University. The R&D was funded by CSIR. The technology is licensed to Lambda Pvt Ltd, Delhi, says H Purushotham, Chairman & Managing Director of the Corporation.

He said that the vision of NRDC is to sign at least one technology licensing agreement a day is close to realisation and thereby assist the Start-Up India and Standup India Missions of the Centre in a big way.

The Delhi-headquartered, 60-year-old corporation, which is part of the Ministry of Science and Technology, has the primary task of promoting indigenous technologies that are developed by national laboratories and institutes under the government and be part of taking them to the commercial market.

Published on November 01, 2016
This article is closed for comments.
Please Email the Editor